Ortho Clinical Diagnostics Holdings Plc (OCDX) Gross Profit Margin starting from the first quarter 2022 to first quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Ortho Clinical Diagnostics Holdings Plc  (NASDAQ: OCDX)


Ortho Clinical Diagnostics Holdings Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OCDX Gross Profit Margin (Apr 03 2022)
Q1 		(Jan 02 2022)
Q4 		(Oct 03 2021)
Q3 		(Jul 04 2021)
Q2 		(Apr 04 2021)
Q1
Y / Y Revenue Change -1.32 %
Seq. Revenue Change -4.01 %
Revenue In Millions $500.10
Gross Profit Margin 50.11 %
Gross Profit Margin Total Ranking # 1943
Gross Profit In Millions $250.60
Y / Y Gross Profit Change -3.09 %
Seq. Gross Profit Change -


Commenting First Quarter 2022 Gross Profit Margin
Ortho Clinical Diagnostics Holdings Plc achieved Gross Profit of $251 millions compare to Gross Loss of $-773.10 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q1 of -4.01 % Ortho Clinical Diagnostics Holdings Plc managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 251 compare to Gross Loss of $-773.10 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 50.11 %, above company average.


Observing first quarter 2022 results within In Vitro & In Vivo Diagnostic Substances industry 7 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1943.
Learn about Gross Margin
OCDX's Gross Profit Margin first quarter 2022 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 8
Healthcare Sector # 371
Overall # 1903

Gross Profit Margin Statistics
High Average Low
51.69 % 49.48 % 47.73 %
(Oct 03 2021)   (Mar 29 2020)


OCDX Gross Income Trends • More of OCDX's Profitabilty Ratios • OCDX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
OCDX's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
OCDX's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for OCDX's Competitors
Gross Profit Margin Profit Margin for Ortho Clinical Diagnostics Holdings Plc's Suppliers
Gross Profit Margin Profit Margin for OCDX's Customers

You may also want to know
OCDX's Annual Growth Rates OCDX's Profitability Ratios OCDX's Asset Turnover Ratio OCDX's Dividend Growth
OCDX's Roe OCDX's Valuation Ratios OCDX's Financial Strength Ratios OCDX's Gross Profit Growth
OCDX's Roa OCDX's Inventory Turnover Ratio OCDX's Growth Rates OCDX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Apr 03 2022, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginApr 03 2022 MRQ Gross ProfitApr 03 2022 MRQ Revenue
Quidelortho Corp  73.83 %$ 739.958  Millions$ 1,002.259  Millions
Myriad Genetics Inc   70.89 %$ 116.900  Millions$ 164.900  Millions
Lantheus Holdings Inc   61.79 %$ 129.070  Millions$ 208.880  Millions
Meridian Bioscience Inc   61.56 %$ 68.477  Millions$ 111.231  Millions
Idexx Laboratories Inc  59.62 %$ 498.753  Millions$ 836.549  Millions
Immucell Corporation  51.72 %$ 3.103  Millions$ 6.000  Millions
Aspira Women s Health inc   50.77 %$ 0.961  Millions$ 1.893  Millions
Ortho Clinical Diagnostics Holdings Plc  50.11 %$ 250.600  Millions$ 500.100  Millions
Alpha Teknova Inc   47.99 %$ 5.349  Millions$ 11.147  Millions
Heska Corporation  44.98 %$ 29.145  Millions$ 64.800  Millions
Neogen Corporation  44.77 %$ 57.412  Millions$ 128.244  Millions
Lucira Health Inc   44.12 %$ 39.916  Millions$ 90.474  Millions
Quotient Limited  38.78 %$ 3.795  Millions$ 9.786  Millions
Biomerica Inc   21.84 %$ 1.673  Millions$ 7.661  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.